ENDOTHELIN-1 AS PREDICTOR OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC CORONARY SYNDROME PATIENTS UNDERGOING CORONARY INTERVENTION
Description
Background: Major Adverse Cardiovascular Events (MACE) are believed to have very low in Chronic Coronary Syndrome (CCS) patients who have undergone percutaneous coronary intervention (PCI). Endothelin-1 had been considered as pro inflammatory biomarker and suggested as a novel prognostic indicator in CCS.
Objective: To prove Endothelin- 1 as predictor of MACE within 1-year evaluation in CCS patients undergoing PCI.
Methods: Analytic observational study with cohort design. The sample were CCS patients whom performed PCI. Endotelin-1 levels were checked before patient undergone PCI. Occurrences of MACE observed within 1 year. The comparison between normally distributed continuous data was performed with T-test, Mann–Whitney test was used for not normally distributed. Comparison between categorical data was performed with the Chi-square test. Cut-off point of Endothelin-1 levels to predict MACE analyzed by Receiver Operating Characteristics (ROC).
Results: Subject of this study were 63 patients. Six patients experienced MACE within 1 year (9.5%) and 57 patients were included in No MACE group (90.5%). Mann Whitney T test showed there were significance differences in Endothelin-1 levels from the two groups (p=0.022). The ROC curve showed cut off point the Endothelin-1 is 4.07 ng/dl with a sensitivity of 83.3%, specificity of 75.4% and accuracy of 76.2%. Based on the AUC value and the accuracy of this study, Endothelin-1 was able to detect MACE within 1 year of follow-up.
Conclusions: Endothelin-1 can be used as predictor of MACE within 1year evaluation in CCS patients undergoing coronary intervention.
Background: Major Adverse Cardiovascular Events (MACE) are believed to have very low in Chronic Coronary Syndrome (CCS) patients who have undergone percutaneous coronary intervention (PCI). Endothelin-1 had been considered as pro inflammatory biomarker and suggested as a novel prognostic indicator in CCS.
Objective: To prove Endothelin- 1 as predictor of MACE within 1-year evaluation in CCS patients undergoing PCI.
Methods: Analytic observational study with cohort design. The sample were CCS patients whom performed PCI. Endotelin-1 levels were checked before patient undergone PCI. Occurrences of MACE observed within 1 year. The comparison between normally distributed continuous data was performed with T-test, Mann–Whitney test was used for not normally distributed. Comparison between categorical data was performed with the Chi-square test. Cut-off point of Endothelin-1 levels to predict MACE analyzed by Receiver Operating Characteristics (ROC).
Results: Subject of this study were 63 patients. Six patients experienced MACE within 1 year (9.5%) and 57 patients were included in No MACE group (90.5%). Mann Whitney T test showed there were significance differences in Endothelin-1 levels from the two groups (p=0.022). The ROC curve showed cut off point the Endothelin-1 is 4.07 ng/dl with a sensitivity of 83.3%, specificity of 75.4% and accuracy of 76.2%. Based on the AUC value and the accuracy of this study, Endothelin-1 was able to detect MACE within 1 year of follow-up.
Conclusions: Endothelin-1 can be used as predictor of MACE within 1year evaluation in CCS patients undergoing coronary intervention.
Files
Restricted
The record is publicly accessible, but files are restricted. Log in to check if you have access.
Request access
If you would like to request access to these files, please fill out the form below.
You need to satisfy these conditions in order for this request to be accepted:
This data contains sensitive patient information and hospital policies regarding the protection of patient information. People
You are currently not logged in. Do you have an account? Log in here